RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-06-29
2018-06-29
2017-06-29
2016-06-29
Total Revenue
2,699,349
2,606,572
2,340,196
2,066,737
1,838,713
Cost of Revenue
1,100,802
1,069,987
978,032
864,992
772,216
Gross Profit
1,598,547
1,536,585
1,362,164
1,201,745
1,066,497
Operating Expenses
Research Development
189,893
180,651
155,149
144,467
118,651
Selling General and Administrative
665,147
645,010
600,369
553,968
482,593
Total Operating Expenses
935,591
900,599
801,901
745,013
625,167
Operating Income or Loss
662,956
635,986
560,263
456,732
441,330
Interest Expense
-
36,156
28,355
28,236
11,206
Total Other Income/Expenses Net
-90,789
-83,282
-26,974
-26,838
-7,419
Income Before Tax
530,553
518,847
521,312
418,743
439,565
Income Tax Expense
111,550
114,255
205,724
76,459
87,157
Income from Continuing Operations
419,003
404,592
315,588
342,284
352,408
Net Income
419,003
404,592
315,588
342,284
352,408
Net Income available to common shareholders
419,003
404,592
315,588
342,284
352,408
Reported EPS
Basic
-
2.83
2.21
2.42
2.51
Diluted
-
2.80
2.19
2.40
2.49
Weighted average shares outstanding
Basic
-
143,111
142,764
141,360
140,242
Diluted
-
144,484
143,987
142,453
141,669
EBITDA
-
786,781
669,627
559,136
528,179